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Mitochondrial importActivation of protein kinase C (PKC) via adenosine receptors is known to be involved in the cardioprotection
of ischemic preconditioning (IPC). Speciﬁcally, activation of PKCε is critical for cardioprotection. There is
ample evidence that PKCε resides in cardiac mitochondria. However, the signals that promote translocation
of PKCε are largely unknown. The present study was designed to determine whether and how adenosine re-
ceptor activation induces translocation of PKCε to mitochondria. Freshly isolated adult rat cardiac myocytes
and rat heart-derived H9c2 were used in the study. Immunoﬂuorescence imaging of isolated mitochondria
showed that PKCε but not PKCδ was localized in mitochondria and this mitochondrial localization of PKCε
was signiﬁcantly increased by adenosine treatment. The adenosine-induced increase in PKCε-positive mito-
chondria was largely prevented not only by PKC inhibitor chelerythrine, but also by the HSP90 inhibitor gel-
danamycin and by siRNA targeting HSP90. Immunoblot analysis from percoll-puriﬁed mitochondria further
demonstrated that adenosine mediated a signiﬁcant increase in mitochondrial PKCε but not PKCδ. This effect
was blocked by inhibiting PKC activity with chelerythrine and bisindolylmaleimide. Furthermore, co-
immunoprecipitation data showed that PKCε but not PKCδ was associated with TOM70 and HSP90, and
this association was enhanced by adenosine treatment. Moreover, adenosine-induced association of PKCε
with TOM70 was reduced by suppressing HSP90 expression with siRNA. In conclusion, we demonstrate
that adenosine induces HSP90-dependent translocation of PKCε to mitochondria, possibly through mitochon-
drial import machinery TOM70. These results point out a novel mechanism in regulating PKC in mitochondria
and suggest an important implication in ischemic preconditioning or postconditioning.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Activation of protein kinase C (PKC) has been shown to be in-
volved in the protective effect of ischemic preconditioning (IPC) and
postconditioning [1–3]. Speciﬁcally, activation of PKC isoform PKCε
is critical for cardioprotection [4–6]. Numerous reports have shown
that selective activation of PKCε confers cardioprotection whereas in-
hibition of PKCε prevents protection.
It has been known that upon activation, PKC translocates to multi-
ple subcellular localizations including mitochondria, nucleus and
plasma membrane [4,7,8]. There is ample evidence that PKC sub-
strates reside in cardiac mitochondria [4,8–11]. While some studies
demonstrate that PKCε is present constitutively within cardiac mito-
chondria, others suggest that mitochondrial translocation of PKCε is
required for protective effect [4,6,9]. Given that most mitochondrialgy, College of Pharmacy, 530
versity, Columbus, OH, 43210,
l rights reserved.proteins are nuclear-encoded, synthesized in the cytosol, and trans-
ported to mitochondria through the protein-conducting pores formed
by translocases of the outer (TOM) and inner (TIM) mitochondrial
membrane [12–14], PKCε may be translocated to mitochondria via
import mechanism in order to interact with its substrates within
mitochondria.
Adenosine receptors are G-protein-coupled receptors and consist
of 4 subtypes — A1, A2A, A2B and A3. It is generally believed that
A1 and A3 receptors are coupled to Gi/Go proteins whereas A2A
and A2B are linked to Gs proteins. While different receptor subtypes
may be associated with distinct signaling pathways, all of these re-
ceptor subtypes are shown to be cardioprotective against ischemia/
reperfusion-induced injury [15]. Importantly, the adenosine-
receptor-mediated cardioprotection has been shown to be associated
with the activation and translocation of PKC isoforms from cytosolic
to membrane fractions [16–19]. However, whether adenosine recep-
tors induce translocation of PKC isoforms to mitochondria is not
known. In recent years, studies have shown that molecular chaperone
heat shock protein (HSP)90 and HSP70, which are linked to IPC, can
facilitate mitochondrial protein transport by association with import
machinery TOM70 in mammalian cells [20,21]. Further, a recent
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machinery are down-regulated during ischemia but preserved by IPC
[22]. In the present study, we tested the hypothesis that adenosine
induces mitochondrial targeting of PKCε, and this process is regulat-
ed by HSP90-dependent mitochondrial import mechanism. We ex-
amined the effect of adenosine on the dynamic movement of PKCε
from cytoplasm to mitochondria and its regulation by TOM70 and
HSP in the freshly isolated adult cardiac myocytes and rat heart-
derived H9c2 cells. We demonstrated that adenosine promoted
PKCε translocation to mitochondria. This regulatory mechanism
largely depends on cellular HSP90, possibly via TOM70. Our data in-
dicate a novel mechanism underlying adenosine-induced PKC target-
ing to mitochondria.2. Materials and methods
2.1. Materials
Rabbit IgG directed against PKCε or PKCδwas obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). Adenosine, adenosine receptor
antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), chelerythr-
ine, bisindolylmaleimide hydrochloride, HSP90 inhibitor geldanamy-
cin were supplied from Sigma-Aldrich (St. Louis, MO). Adenosine
was dissolved in deionized water. All other drugs were dissolved
in dimethyl sulfoxide, which did not exceed a ﬁnal concentration
of 0.1%.2.2. Isolation of cardiomyocytes
Adult rat ventricular myocytes were isolated from adult Sprague
Dawley rats (250 to 300 g) by enzymatic dissociation [23,24]. In
brief, hearts were excised and retrogradely perfused via the aorta
with oxygenated (100% O2) Tyrode's solution containing (mM) NaCl
126, KCl 5.4, CaCl2 1.0, MgCl2 1.0, NaH2PO4 0.33, HEPES 10, and glu-
cose 10 at 37 °C. The perfusate was then changed to a Tyrode's solu-
tion that is nominally Ca2+ free but otherwise had the same
composition. The hearts were perfused with the same solution con-
taining collagenase for 20–30 min. Softened ventricular tissues were
removed, cut into small pieces, and mechanically dissociated by tritu-
ration. The digested cells were initially stored in a solution containing
(mM) KCl 20, KH2PO4 10, glucose 10, potassium glutamate 70, ß-
hydroxybutyric acid 10, taurine 10, mannitol 5, and EGTA 5, along
with 1% albumin, and then transferred to normal Tyrode solution.
Cells were incubated in Tyrode solution with various agents for 5 to
10 min at 37 °C prior to subsequent biochemical and immunoﬂuores-
cence experiments.2.3. Small interfering RNA
The small interfering RNA (siRNA) oligonucleotide targeting rat
HSP90 α and β was purchased from Ambion Inc. (Austin, TX, USA).
A negative control siRNA (scrambled) was included to monitor non-
speciﬁc effects.2.4. Cell culture and transfection
Rat heart-derived H9c2 cells were cultured in Dulbecco's modi-
ﬁed Eagle's medium DMEM/F12 supplemented with 10% fetal bovine
serum, 2 mM glutamine, and penicillin–streptomycin [25]. H9c2
cells were transfected with siRNA using Hi-perfect siRNA transfec-
tion reagent [25]. Experiments were carried out 48 to 72 h after
transfection.2.5. Preparation of the cytosolic or mitochondrial fraction or intact
mitochondria
Intact mitochondria or mitochondrial or cytosolic fractions were
prepared from H9c2 cells and adult rat cardiomyocytes by differential
centrifugation [19,25,26]. For Western blot experiments, mitochon-
drial fraction was further puriﬁed by 30% percoll ultracentrifugation
[25,26]. For mitochondrial colocalization experiments, cells were
stained with a mitochondrial marker MitoTracker (200 nM) for
15 min before fractionation. In brief, cells after treatment with vari-
ous agents at 37 °C were collected in an ice-cold homogenizing buffer
containing (in mM) 250 mM sucrose, 5 mM HEPES, 5 mM EDTA, and
protease inhibitor cocktail. Two 15 s homogenization cycles were
performed on ice. The homogenate was centrifuged at 1000 g for
10 min at 4 °C to remove nuclei and debris. The mitochondrial and cy-
tosolic fractions were prepared by centrifugation at 8500×g for
20 min at 4 °C. The supernatants were then centrifuged at 27,000 g
for 1 h at 4 °C, and the resulting supernatant was used as the soluble
cytosolic fraction. The pellet containing the mitochondrial fraction
was resuspended in the homogenizing buffer and further centrifuged
at 8500 g for 20 min at 4 °C. The washed mitochondria were then
resuspended. For percoll puriﬁcation, the crude mitochondrial sus-
pension (0.5 ml) was laid on the top of 10 ml of a solution containing
30% percoll, 0.25 M sucrose, 1 mM EDTA and 10 mM HEPES (pH 7.4).
Self-generating percoll gradient was developed by centrifugation at
95,000 g for 30 min at 4 °C. Mitochondrial band was collected by a
Pasteur pipette and washed in the homogenizing buffer.
2.6. Western blotting
Immunoblot analysis was carried out from the cytosolic and mito-
chondrial fractions [19,26]. The purity of mitochondrial or cytosol
fractions was evaluated using antibody against the mitochondrial
marker protein prohibitin, the cytosol marker GAPDH and the plasma
membrane marker Na+/K+ ATPase to ensure there is no signiﬁcant
contamination in the cytosolic or mitochondrial fraction. Brieﬂy, the
percoll-puriﬁed mitochondrial and cytosolic fractions were dena-
tured in a sample buffer. Equal amounts of proteins were loaded
and electrophoresed on 10% SDS-polyacrylamide gels and transferred
onto nitrocellulose membranes. The transferred blots were blocked
with 5% nonfat milk in Tris-buffered saline (TBS, 150 mM NaCl,
20 mM Tris–HCl, pH 7.4) and incubated for 2 h at room temperature
or overnight at 4 °C with primary antibodies in TBS, 0.05% Tween
20. After washing, the blots were reacted with peroxidase-
conjugated secondary antibodies for 45 min and developed using
the ECL detection system.
2.7. Co-immunoprecipitation
Immunoprecipitation experiments were performed as reported
previously [19,27,28]. Cells were pretreated with or without adeno-
sine prior to homogenization. The mitochondrial fraction was incu-
bated with primary antibody for 2 h at 4 °C. Antigen-antibody
complexes were captured with r-protein-G agarose (4 °C, 2 h). Aga-
rose beads were washed 4-times with solubilization buffer before re-
moval of bound proteins by boiling in SDS sample buffer. Samples
were resolved by SDS-PAGE, transferred onto a nitrocellulose mem-
brane, and analyzed by probing with various antibodies.
2.8. Immunoﬂuorescence microscopy
As described previously [27], intact mitochondria were isolated
from cells pretreated with MitoTracker and/or other agents. Mito-
chondria were ﬁxed with 4% formaldehyde in PBS for 30 min, blocked,
permeabilized in 5% goat serum in PBS with 0.1% Triton X-100
(30 min), and labeled with primary antibody for 2 h. Mitochondria
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conjugated secondary antibody for 1 h. Immunoﬂuorescence was vi-
sualized with Nikon ﬂuorescence microscope. All images were ana-
lyzed using a background subtraction method ofﬂine.
2.9. Data analysis
Group data were presented as means±SE. Multiple group means
were compared by ANOVA followed by LSD post hoc test. Differences
with a two-tailed Pb0.05 were considered statistically signiﬁcant.
3. Results
3.1. Effect of adenosine on mitochondrial localization of PKCε
To investigate role of adenosine on mitochondrial localization of
PKCε, we examined whether adenosine promotes mitochondrial
translocation of PKCε and whether this translocation is dependent
on PKC activation. Given that determining whether proteins are lo-
calized in mitochondria is difﬁcult in intact adult cardiomyocytes
due to tightly packed myoﬁbrils and sub-organelles, we isolated mi-
tochondria from adult rat cardiac myocytes and analyzed mitochon-
dria for the presence of protein of interest. This method has been
demonstrated to be an effective way to localize proteins inFig. 1. Effect of adenosine on mitochondrial localization of PKCε. Isolated mitochondria we
Ade+chelerythrine (Che) or Ade+8-Cyclopentyl-1,3-dipropylxanthine (DPCPX). (A) Rep
anti-PKCε antibody and MitoTracker Green. Arrows indicate PKCε-positive mitochondria. S
ﬂuorescence. Results are data from 4 to 6 independent experiments. **pb0.01 vs. control, #mitochondria [20,26]. The freshly isolated adult rat cardiac myocytes
were pretreated without or with adenosine (10 μM), adenosine plus
chelerythrine (10 μM), or adenosine plus DPCPX (100 nM) for 5–
10 min. The concentration of the PKC inhibitor chelerythrine was
chosen based on our previous studies [26,29,30]. Cells were also
stained with a mitochondria-selective probe MitoTracker-green be-
fore mitochondrial fractionation. Intact mitochondria were obtained
from cardiac myocytes by differential centrifugation. As shown in
Fig. 1A, a small portion of PKCε was localized in mitochondria that
were identiﬁed by MitoTracker-green. However, adenosine pretreat-
ment signiﬁcantly increased mitochondrial localization of PKCε, as
evidenced by increased yellow punctate staining. The adenosine-
induced increase in mitochondrial PKCε was largely blocked by PKC
inhibitor chelerythrine. The quantiﬁcation analysis (Fig. 1B) revealed
that the percent of PKCε-positive mitochondria, which was normal-
ized to total mitochondria, was signiﬁcantly increased by adenosine
treatment (72.3±7.6% vs. 21.1±4.5%, adenosine vs. control,
pb0.01) and this effect was largely eliminated by DPCPX (31.5±
6.4% vs. 72.3±7.6%, adenosine plus DPCPX vs. adenosine, pb0.01).
The adenosine effect on PKCε was also prevented by chelerythrine
(39.8±6.69% vs. 72.3±7.6%, adenosine plus chelerythrine vs. adeno-
sine, pb0.01). The data were collected from 4 to 6 independent ex-
periments. Fig. 1B (right panel) shows that PKCδ was not detected
in mitochondria from cells with or without adenosine treatment.re prepared from adult rat cardiac myocytes treated without or with adenosine (Ade),
resentative immunoﬂuorescence images of isolated mitochondria double labeled with
cale bar: 10 μm. (B) Percentage of mitochondria with PKCε-positive or PKCδ-positive
#pb0.01 vs. adenosine.
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β2 in the rat cardiac myocytes. We found that none of them was sig-
niﬁcantly present in mitochondria in response to adenosine stimula-
tion (data not shown). These results suggest that PKCε is present in
mitochondria at a relatively low level under control condition, but
can be increased by adenosine-induced PKC activation.
3.2. Effect of adenosine on translocation of PKCε from the cytosol to
mitochondrial fraction
To further conﬁrm the effect of adenosine on mitochondrial trans-
location of PKCε, immunoblot analysis was carried out for percoll-
puriﬁedmitochondrial fraction prepared from adult rat cardiomyocytes
pretreated without or with adenosine, adenosine plus chelerythrine, or
adenosine plus bisindolylmaleimide (30 nM) for 5–10 min. Enrich-
ment of mitochondria was identiﬁed by antibody against prohibitin,
a molecular marker of mitochondria. Immunoblots with antibody
against Na+/K+-ATPase, a plasma membrane protein marker
revealed no signiﬁcant contamination of mitochondrial or cytosolic
fraction with plasma membrane. GAPDH and prohibitin also serve
as loading control for cytosol and mitochondrial fractions, respec-
tively. Western blot with antibody against PKCε revealed aFig. 2. Effect of adenosine on translocation of PKCε to mitochondria from cytosol. Subcellular
out or with adenosine (Ade), or Ade+chelerythrine (Che) or bisindolylmaleimide (Bis). (A)
cytosol ratio as indexes of PKCε or PKCδ translocation to mitochondrial from cytosol. They w
3 independent experiments. *pb0.05 vs. control, #pb0.05 vs. adenosine.prominent protein band in mitochondrial fraction whereas antibody
against PKCδ detected a faint band in mitochondria (Fig. 2A). Adeno-
sine treatment induced a signiﬁcant redistribution of PKCε but not
PKCδ from the cytosol to mitochondria. The mitochondria to cytosol
ratios of PKCε increased about 2.5 fold in adenosine-treated cells
when compared to control group (Fig. 2B, 274.4±92.1% vs. control,
pb0.05, n=3). The PKC inhibitor chelerythrine blocked the effect of
adenosine-induced translocation of PKCε to mitochondria (166.7±
16.48% vs. 274.4±92.1%, adenosine plus chelerythrine vs. adenosine,
pb0.05, n=3). Similar resultswere also obtainedwith a highly selective
PKC inhibitor bisindolylmaleimide (115.7±8.1% vs. 202.5±37.4%,
adenosine plus bisindolylmaleimide vs. adenosine, pb0.05, n=3). In
contrast, no signiﬁcant amount of PKCδwas redistributed to mitochon-
dria in response to adenosine treatment. These results indicate that
adenosine induces translocation of PKCε to mitochondria from cytosol
via activation of PKC.
3.3. Effect of inhibiting HSP90 activity on adenosine-mediated mitochondrial
localization of PKCε
HSP90 has been linked to cardioprotection of ischemic precondi-
tioning and mitochondrial import [31]. We sought to determinefractionation was performed from adult rat cardiac myocytes which were treated with-
Representative Western blots with antibody against PKCε or PKCδ. (B) Mitochondria to
ere calculated by relative densitometry and normalized to control. Results are data from
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translocation of PKCε. Cardiomyocytes freshly isolated from adult rat
hearts were pretreated with or without adenosine or adenosine plus
a selective HSP90 inhibitor geldanamycin (1 μM) for 5–10 min before
mitochondrial fractionation. As shown in Fig. 3, geldanamycin signiﬁ-
cantly inhibited adenosine-induced increase inmitochondrial PKCε, as
indicated by reduction in PKCε-positive mitochondria. Quantitative
data showed that adenosine induced about 3-fold increase in PKCε-
positive mitochondria which was signiﬁcantly eliminated by geldana-
mycin (38.2±7.4% vs. 72.3±7.6%, adenosine plus geldanamycin vs.
adenosine, pb0.01). These data indicate that adenosine increases
translocation of PKCε to mitochondria, possibly through enhancing
HSP90 activity.
3.4. Effect of suppression of HSP90 with siRNA on adenosine-mediated
mitochondrial localization of PKCε
In order to conﬁrm the speciﬁc role of HSP90 on adenosine-
induced mitochondrial translocation of PKCε, we studied the effect
of suppressing endogenous HSP90 with siRNA targeting HSP90
(α and β isoforms) in H9c2 cells. While H9c2 cells are myoblast cellFig. 3. Effect of inhibiting HSP90 activity on adenosine-induced increase in mitochondrial PK
out or with adenosine (Ade), or Ade+geldanamycin (Geld). (A) Representative immunoﬂ
and MitoTracker Green. Arrows indicate PKCε-positive mitochondria. Scale bar: 10 μm. (B)
to 6 independent experiments. **Pb0.01 vs. control, ##pb0.01 vs. adenosine.line derived from embryonic rat heart, these cells have been used ex-
tensively for studies involving cardioprotection, heat shock proteins
and protein kinases. We employed H9c2 cells because they display
many properties similar to those in adult cardiomyocytes and are eas-
ily transfected [25,32]. As shown in Fig. 4, transfection of H9c2 cells
with siRNA targeting HSP90 signiﬁcantly reduced the expression of
endogenous HSP90. Similar to that in cardiac myocytes, adenosine
pretreatment in H9c2 cells increased the mitochondrial targeting of
PKCε (53.6±4.7% vs. 14.5±2.1%, adenosine vs. control, pb0.01),
and the effect was largely prevented by pretreatment with cheler-
ythrine (21.6±5.9% vs. 53.6±4.7%, adenosine plus chelerythrine vs.
adenosine, pb0.01). Interestingly, suppression of HSP90 with siRNA
signiﬁcantly prevented adenosine-induced translocation of PKCε to
mitochondria (23.60±7.21% vs. 53.6±4.7%, adenosine plus HSP90-
siRNA vs. adenosine, pb0.01), while the negative scrambled siRNA
did not have any effect on adenosine-induced increase in PKCε-posi-
tive mitochondria (Fig. 4A and C,). The adenosine-induced increase in
mitochondrial PKCε was also inhibited by DPCPX (Fig. 4C, 20.8±4.2%
vs. 53.6±4.7%, adenosine plus DPCPX vs. adenosine, pb0.01). Fig. 4B
showed signiﬁcant suppression of HSP90 expression with siRNA
targeting HSP90 (α and β). The data were analyzed from 4 to 6Cε. Isolated mitochondria were prepared from adult rat cardiac myocytes treated with-
uorescence images of isolated mitochondria double labeled with anti-PKCε antibody
Percentage of mitochondria with PKCε-positive ﬂuorescence. Results are data from 4
Fig. 4. Effect of suppressing HSP90 protein expression with HSP90 siRNA on adenosine-induced increase in mitochondrial PKCε. Mitochondria were prepared from rat heart-derived
H9c2 cells without or with the treatment of adenosine (Ade), Ade+chelerythrine (Che), Ade+HSP90-siRNA, or Ade+control siRNA (C-siRNA). (A) Representative immunoﬂuo-
rescence images of isolated mitochondria double labeled with anti-PKCε antibody and MitoTracker Green. Arrows indicate PKCε-positive mitochondria. Scale bar: 10 μm. (B) West-
ern blot of total cellular fraction from H9c2 cells transfected with HSP90-siRNA or C-siRNA. (C) Percentage of mitochondria with PKCε-positive ﬂuorescence. Results are data from 4
to 6 independent experiments. **Pb0.01 vs. control, ##pb0.01 vs. adenosine.
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HSP90 is involved in adenosine-induced translocation of PKCε to
mitochondria.
3.5. Effect of adenosine on co-immunoprecipitation of PKCε, HSP90
and TOM70
To determine whether PKCε associates with HSP90, HSP70 or/and
TOM70 and whether this association can be up-regulated by adeno-
sine, we performed co-immunoprecipitation in the mitochondrial
fraction prepared from cardiomyocytes pretreated with or without
adenosine (10 μM). The total cellular HSP90 or HSP70 was not altered
by adenosine treatment (data not shown). When the mitochondrial
homogenates were immunoprecipitated with anti-HSP90, anti-PKCε
or anti-TOM70 antibody, the immunoblotting revealed that HSP90,PKCε and TOM70were associatedwith each other. In contrast, no signif-
icant amount of PKCδ or HSP70 was detected in the HSP90, TOM70 or
PKCε precipitates (Fig. 5A). Pretreatmentwith adenosine signiﬁcantly in-
creased PKCε co-precipitated by anti-HSP90 antibody (214.3±56.3% vs.
control, pb0.05) or anti-TOM70 antibody (228.3±30.8% vs. control,
pb0.05). Similarly, adenosine also increased TOM70 level co-
precipitated by anti-HSP90 (195.9±17.8% vs. control, pb0.05) or
anti-PKCε (215.8±36.7% vs. control, pb0.05), and increased HSP90
co-precipitated by anti-PKCε (183.3±4.3% vs. control, pb0.05) or anti-
TOM70 antibody (187.9±17.6% vs. control, pb0.05). However, HSP70
level co-precipitated by anti-PKCε, anti-HSP90 or anti-TOM70 antibody
was not increased signiﬁcantly by adenosine. Adenosine did not signiﬁ-
cantly alter the recovery of HSP90, PKCε or TOM70 in the HSP90, PKCε
and TOM70 precipitates, respectively. As a control, HSP90, PKCε or
TOM70 was not detected in the homogenates treated with control
Fig. 5. Co-immunoprecipitation of HSP90, PKCε and TOM70 from adult cardiac myocytes. (A) Immunoprecipitation was performed with anti-HSP90, anti-PKCε or anti-TOM70 an-
tibody from mitochondrial fraction or protein lysate (Input) of cardiac myocytes treated without or with adenosine (Ade). (B) Quantiﬁcation of co-precipitated HSP90, PKCε and
TOM70. Results are data from 3 independent experiments. *Pb0.05 vs. control.
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5–10 min did not signiﬁcantly increase HSP90 expression level but pro-
moted association of HSP90, TOM70 and PKCε.
3.6. Effect of suppressing HSP90 expression on association of PKCε
and TOM70
To determine whether adenosine-mediated association of PKCε
with TOM70 is dependent on HSP90, we performed co-
immunoprecipitation using the mitochondrial fraction prepared
from H9c2 cells pretreated with or without adenosine (10 μM).
Our data showed that TOM70 was co-precipitated by PKCε under
the basal condition and this association was enhanced by adenosine
treatment (Fig. 6, 186.6±16.7% vs. control, pb0.05). However, sup-
pression of HSP90 with siRNA signiﬁcantly inhibited adenosine-
induced association of PKCε with TOM70 (97.6±16.2% vs. 186.6±
16.7%, adenosine plus HSP90-siRNA vs. adenosine, pb0.05). The
basal level of association of PKCε and TOM70 was not altered by
HSP90-siRNA, indicating the importance of adenosine-induced in-
crease in HSP90 activity for association of PKCε with TOM70. As a
control, TOM70 was not detected in the homogenates treated with
control antibody IgG. These results indicate that pretreatment with
adenosine for 5–10 min signiﬁcantly enhanced association of PKCε
with TOM70; the effect was prevented by suppression of HSP90
expression.4. Discussion
Our study has demonstrated that adenosine promotes transloca-
tion of a novel PKC isoform, PKCε, to mitochondria. We found that
adenosine receptor activation induced a rapid association of PKCε
with TOM70, which is dependent on HSP90. Speciﬁcally, we showed
that activation of adenosine receptors induced a selective transloca-
tion of PKCε (but not PKCδ) from the cytosol to mitochondria. We
also showed that adenosine-mediated PKCε translocation to mito-
chondria was signiﬁcantly reduced by inhibiting HSP90 function or
suppressing HSP90 expression. Further, our data indicate that
HSP90 is critical for association of PKCε and TOM70. We demonstrate
for the ﬁrst time that adenosine receptor activation induces selective
translocation of PKCε to mitochondria. This translocation process is
associated with the mitochondrial import machinery TOM70 and is
dependent on HSP90 function.
It is well known that upon stimulation, PKC isoforms are translo-
cated to their distinct subcellular membrane regions where the acti-
vated isoforms are anchored close to their particular substrates [33].
Studies have shown that PKCε is present in the mitochondrial inner
membrane and interacts with mitochondrial components, such as
the pore component of cardiac mitochondrial permeability transition
pore [4,10]. Phosphorylation by PKCε enhances the activity of cyto-
chrome c oxidase subunit IV [11]. Although numerous evidence sug-
gests that adenosine receptors are linked to PKC activation [16,34],
Fig. 6. Effect of HSP90 siRNA on co-precipitation of PKCε and ΤΟΜ70. (A) Immunopre-
cipitations of mitochondrial fractions from H9c2 cells treated without or with adeno-
sine (Ade), HSP90-siRNA, or Ade+HSP90-siRNA. (B) Quantiﬁcation of TOM70 co-
precipitated by PKCε. Results are data from 3 independent experiments. *Pb0.05 vs.
control, #pb0.05 vs. adenosine.
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tochondria after activation of adenosine receptors. In the present
study, experiments were designed to determine whether PKCε is in-
deed localized to mitochondria under basal condition and whether
the mitochondrial localization of PKCε is regulated by adenosine. Spe-
ciﬁcally, we examined whether adenosine induced translocation of
PKCε from cytosol to mitochondria. We found that under basal condi-
tions, the level of PKCε in mitochondria was relatively low but
enhanced signiﬁcantly following adenosine stimulation. In contrast,
no signiﬁcant amount of PKCδ was detected in mitochondria
with or without adenosine. These observations provide the novel
evidence that adenosine induces selective translocation of PKCε to
mitochondria.
Althoughmany studies have reported PKCε localized to mitochon-
dria [4,10], the existence of PKCε in mitochondria is still puzzling, in
particular on the mitochondrial inner membrane. It is well known
that many proteins translocated into mitochondria possess N-
terminal mitochondrial targeting sequence. Translocases in mito-
chondria recognize the signal sequence and then mediate the import
and sorting of proteins. However, no mitochondrial targeting se-
quence in PKCε and other PKC isoforms has been found. It is therefore
not clear how PKCε gets into mitochondria. It is generally believed
that mitochondrial import machinery TOM20 recognizes classical N-
terminal mitochondrial targeting sequences whereas TOM70
interacts with internal targeting sequences such as those in the
multitransmembrane carrier proteins of the inner mitochondrial
membrane [35–37]. It is noted that some proteins lack the N-
terminal mitochondrial targeting sequence but are targeted to mito-
chondrial inner membrane [20]. The present study shows that aden-
osine promotes association of PKCε with the mitochondrial import
machinery TOM70, indicating the importance of mitochondrialimport in PKCε translocation to mitochondria. Furthermore, the
translocation process appears to be dependent on HSP90, a protein
that has been shown to assist with mitochondrial import [31]. Our
data demonstrate that suppressing HSP90 expression with speciﬁc
siRNA prevented adenosine-induced association of PKCε and
TOM70, indicating that both HSP90 and TOM70 are important for mi-
tochondrial translocation of PKCε. It has been shown that some com-
ponents of the mitochondrial import machinery are down-regulated
during ischemia but preserved by IPC [22], suggesting that mitochon-
drial import could be a novel mechanism by which PKCε confers car-
dioprotection [31]. Indeed, a recent study by Budas and colleagues
indicates that HSP90-mediated mitochondrial import of PKCε plays
an important role in the protection of the myocardium from ischemia
and reperfusion injury [38].
In addition to translocation to mitochondria, PKC has been
shown to translocate to the plasma membrane, nucleus and other
subcellular organelles upon activation. We have recently discovered
that adenosine A1 receptor activation induces PKCε and PKCδ trans-
location to the caveolar plasma membrane [19]. Here, we showed
that adenosine receptor activation also caused PKCε translocation
of mitochondria. Although different receptor subtypes and their sig-
naling may be associated with differential translocation of PKC iso-
forms, our observations suggest that adenosine receptor signaling
can potentially inﬂuence various subcellular localizations of different
PKC isoforms and may serve distinct roles in a variety of cellular
events. There is growing evidence that adenosine contributes signif-
icant cardioprotection via adenosine receptor subtypes and their dis-
tinct signal transduction pathways, such as PKC isoforms and their
down-stream signaling including mitogen-activated protein kinase
and PI3 kinase/protein kinase B [39]. While it is well-known that
adenosine A1 receptors are associated with PKC activation and
translocation to the plasma membrane via PLC/PLD, recent reports
indicate that adenosine A1 receptors-induced PKC activation may
further facilitate adenosine A2b receptor signaling which then regu-
lates survival kinases including PI3 kinase and ERK [39–41]. Because
PI3 kinase has also been shown to activate PKC either via direct ac-
tivation by lipid products or via phosphorylation by PDK1 [42], it is
likely that adenosine receptors may cause PKC activation and target-
ing to distinct subcellular localizations such as mitochondria via
adenosine A2b receptor-dependent signaling pathways. A recent
study indicates that A2b receptors are present in or near mitochon-
dria rather than on the sarcolemma, suggesting the possible involve-
ment of mitochondria in adenosine A2b receptors-mediated
signaling [43].
Our ﬁnding indicates a novel mechanism involved in the
adenosine-mediated PKC signaling that is dependent on mitochon-
drial import machineries. Adenosine receptor signaling has been as-
sociated with cardioprotection against ischemic/reperfusion injury
[15]. Given that most of mitochondrial proteins are imported from
cytosol via translocons on the mitochondrial membranes, the dy-
namic regulation of protein import to mitochondria by adenosine
signaling could be a novel mechanism mediating cardioprotection.
The number of PKC substrates in mitochondria has been proposed,
such as aldehyde dehydrogenase 2, cytochrome c oxidase subunit
IV, mitochondrial permeability transition pore, and mitochondrial
ATP-sensitive K+ channels [4]. The present study provides a
detailed understanding of the molecular mechanism underlying
adenosine-mediated mitochondrial targeting of PKC isoforms,
which increase our knowledge about adenosine-mediated cardiopro-
tection against ischemic injury, and may lead to identiﬁcation of
potential therapeutic targets.
In summary, we demonstrate that adenosine receptor activation
induces translocation of PKCε to mitochondria, and this process is as-
sociated with TOM70 and dependent on HSP90. Our observations
may have important implication in cardioprotection associated with
adenosine receptor signaling.
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